Although self or tumor-reactive naïve CD8+ T cells have the capacity to respond to tumor antigens and differentiate into cytotoxic effector cells, some major limitations are the relatively low number of self/tumor-specific lymphocytes that result from negative selection during thymic maturation and inadequate magnitude of stimulation from antigens in the tumor environment12. This evidence concerns the gene CD8A and neoplasm.